RainDance, Life Technologies Pen Co-Marketing Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has struck an agreement with Life Technologies under which the companies will co-market a combined solution that pairs microdroplet PCR-based sequence enrichment with next-generation sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.